Welcome from the Interim Chief
Welcome to the Division of Allergy, Immunology and Rheumatology (AIR). This Division has a long history of providing excellence in patient care, medical research, and education that dates back to the 1950’s. Our current faculty and staff are not only committed to carrying on this tradition but are also recognized nationally as leaders in their field.
We provide timely, comprehensive, individualized, state-of-the-art medical care to patients with musculoskeletal, autoimmune, and allergic diseases. We act as advocates for our patients and seek to improve treatments outcomes and quality of life.
Our faculty perform cutting edge investigation in basic science and translational research as we seek to expand our understanding of the mechanisms that underlie inflammatory, allergic and autoimmune disorders, with the goal of developing more effective and less toxic treatments.
We are also committed to educating the next generation of Allergists/Immunologists and Rheumatologists. Being a combined division with close ties to Pediatrics as well as many other Departments in the Medical Center including Orthopedics, Dermatology and others offers our fellows numerous unique opportunities.
Jennifer Anolik, M.D., Ph.D.
Interim Division Chief
Associate Chair of Research, Department of Medicine
Upcoming Speakers and Events
AIR/Derm Grand Rounds
Misha Rosenbach, MD
University of Pennsylvania
September 29, 2022
Rheumatology Grand Rounds
Professor Annamaria Iagnocco
Università degli Studi di Torino, Turin Italy
November 17, 2022
$10 Million NIH Grant Funds Research on Treatments for Autoimmune Diseases
The Allergy, Immunology & Rheumatology division, along with other URMC collaborators, has earned a multimillion-dollar grant for five years to research autoimmune diseases. Jennifer Anolik, M.D., Ph.D., professor and interim chief of Allergy/Immunology & Rheumatology, and Christopher Ritchlin, M.D., M.P.H., professor of Allergy/Immunology & Rheumatology, will lead rheumatoid arthritis and psoriasis/psoriatic arthritis research teams, respectively. Dr. Anolik was extensively involved in an earlier project, “Accelerating Medicines Partnership (AMP) in RA and SLE: Cellular dynamics at the synovium-bone interface in RA,” where she studied the interaction of B cells and T cells in joint destruction in autoimmune diseases and served as co-chair of the NIH AMP RA/Lupus network.
Learn more about these grants.